These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30595759)

  • 1. Enhanced nanoparticle delivery exploiting tumour-responsive formulations.
    Bennie LA; McCarthy HO; Coulter JA
    Cancer Nanotechnol; 2018; 9(1):10. PubMed ID: 30595759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on dual targeting strategy for cancer treatment.
    Taghipour YD; Zarebkohan A; Salehi R; Rahimi F; Torchilin VP; Hamblin MR; Seifalian A
    J Control Release; 2022 Sep; 349():67-96. PubMed ID: 35779656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The development of novel tumor targeting delivery strategy].
    Gao HL; Jiang XG
    Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-therapeutics for modulating the tumour microenvironment: Design, development, and clinical translation.
    Adityan S; Tran M; Bhavsar C; Wu SY
    J Control Release; 2020 Nov; 327():512-532. PubMed ID: 32800879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing Hydrogels for On-Demand Therapy.
    Oliva N; Conde J; Wang K; Artzi N
    Acc Chem Res; 2017 Apr; 50(4):669-679. PubMed ID: 28301139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites.
    Attia MF; Anton N; Wallyn J; Omran Z; Vandamme TF
    J Pharm Pharmacol; 2019 Aug; 71(8):1185-1198. PubMed ID: 31049986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of nanoparticle photosensitizer drug delivery uptake systems for photodynamic treatment of lung cancer.
    Mokwena MG; Kruger CA; Ivan MT; Heidi A
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():147-154. PubMed ID: 29588217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration.
    Dai J; Han S; Ju F; Han M; Xu L; Zhang R; Sun Y
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):860-873. PubMed ID: 29771149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis.
    Huang S; Shao K; Liu Y; Kuang Y; Li J; An S; Guo Y; Ma H; Jiang C
    ACS Nano; 2013 Mar; 7(3):2860-71. PubMed ID: 23451830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids.
    Gu J; Chen X; Fang X; Sha X
    Acta Biomater; 2017 Jul; 57():156-169. PubMed ID: 28442415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-responsive multifunctional peptide coating of gold nanorods improves tumor targeting and photothermal therapy efficacy.
    Wu L; Lin B; Yang H; Chen J; Mao Z; Wang W; Gao C
    Acta Biomater; 2019 Mar; 86():363-372. PubMed ID: 30660006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating.
    Mei L; Zhang Q; Yang Y; He Q; Gao H
    Int J Pharm; 2014 Oct; 474(1-2):95-102. PubMed ID: 25138251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox sensitive PEG controlled octaarginine and targeting peptide co-modified nanostructured lipid carriers for enhanced tumour penetrating and targeting in vitro and in vivo.
    Wang H; Sun M; Li D; Yang X; Han C; Pan W
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):313-322. PubMed ID: 28362124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor targeting and microenvironment-responsive nanoparticles for gene delivery.
    Huang S; Shao K; Kuang Y; Liu Y; Li J; An S; Guo Y; Ma H; He X; Jiang C
    Biomaterials; 2013 Jul; 34(21):5294-302. PubMed ID: 23562171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to Improve Macromolecule and Nanoparticle Accumulation in the Tumor Microenvironment by the Enhanced Permeability and Retention Effect.
    Ejigah V; Owoseni O; Bataille-Backer P; Ogundipe OD; Fisusi FA; Adesina SK
    Polymers (Basel); 2022 Jun; 14(13):. PubMed ID: 35808648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Assembly of Gold Nanoparticles Shows Microenvironment-Mediated Dynamic Switching and Enhanced Brain Tumor Targeting.
    Feng Q; Shen Y; Fu Y; Muroski ME; Zhang P; Wang Q; Xu C; Lesniak MS; Li G; Cheng Y
    Theranostics; 2017; 7(7):1875-1889. PubMed ID: 28638474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment.
    Guo F; Fu Q; Jin C; Ji X; Yan Q; Yang Q; Wu D; Gao Y; Hong W; Li A; Yang G
    Drug Deliv; 2019 Dec; 26(1):1027-1038. PubMed ID: 31691601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembling micelle-like nanoparticles with detachable envelopes for enhanced delivery of nucleic acid therapeutics.
    Battogtokh G; Ko YT
    Mol Pharm; 2014 Mar; 11(3):904-12. PubMed ID: 24446871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancement in integrin facilitated drug delivery.
    Arosio D; Casagrande C
    Adv Drug Deliv Rev; 2016 Feb; 97():111-43. PubMed ID: 26686830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.